Belle Health Review

Belle Health: flat-rate compounded GLP-1, with an FDA letter you should know about

Belle Health is a national direct-to-consumer telehealth service built around one genuinely useful idea: you pay the same price every month no matter how high your dose climbs. It dispenses compounded semaglutide and tirzepatide, throws in free weekly dietitian sessions, and — unusually — names every pharmacy it works with. It is also operating under a February 2026 FDA Warning Letter for how it marketed those drugs. Both things are true, and you should weigh them together before signing up.

How the flat-rate pricing actually works

Most compounded-GLP-1 programs quietly charge you more as your provider titrates you up. The dose you need at month six can cost noticeably more than the dose you started on. Belle doesn't do that. Semaglutide is $119 a month at every dose, full stop, with no escalation surcharge as you move up the ladder. That single, predictable number is the company's whole pitch, and for a medication you may take for a year or more, it removes a real source of bill shock.

Tirzepatide is priced separately at just under two hundred dollars a month, with a catch worth reading twice. That rate requires a three-month bundle commitment, so you're paying for a quarter up front rather than testing it month to month. For comparison, the category median sits around $169, so Belle's semaglutide rate lands comfortably below the middle of the pack while its tirzepatide rate is roughly average — and only at the bundle price.

There's no separate consultation fee and no membership fee. The monthly price is advertised as all-in: the medication itself, the provider visit, supplies, shipping, and ongoing access to your clinician. There is no first-month teaser rate to lure you in — what you see is the standing price, which is at least honest.

What's actually included

• The compounded medication, shipped to your door
• The telehealth provider consultation, with no extra consult fee
• Shipping and injection supplies
• Free weekly check-ins with a registered dietitian — a real coaching benefit most rivals charge extra for or skip entirely

The medications and the pharmacies behind them

Belle offers compounded semaglutide and compounded tirzepatide — the same active ingredients as the brand-name injectables, but mixed by compounding pharmacies rather than the original manufacturer. There is no brand-name Wegovy, Ozempic, or Zepbound option here, and there is no oral pill; this is injectable compounded medication only.

Where Belle stands out from nearly every competitor is transparency about who makes the drug. Most compounding telehealth brands won't tell you which pharmacy fills your prescription. Belle names five in its own terms: Striker Pharmacy in Texas, Strive Pharmacy in Arizona, OptioRx, Enovex Compounding Pharmacy, and Braun PharmaCare. That is about as complete as pharmacy disclosure gets in this market, and it lets a motivated patient actually look up the facilities involved.

The flip side of a five-pharmacy network: your refill may not come from the same place every time, and compounded formulations can vary slightly between pharmacies. Compounded drugs are also not FDA-approved — the FDA doesn't review them for safety, effectiveness, or quality the way it does brand-name products. That's true of every compounding provider, but it matters more here given what follows.

The FDA Warning Letter — read this before you decide

On February 20, 2026, the FDA issued Warning Letter 721795 to Belle Health LLC. The agency determined that Belle's website displayed compounded semaglutide and tirzepatide with Belle's own branding in a way that suggested Belle manufactured the drugs — which it does not — making the products misbranded under the federal misbranding statutes. This is not a footnote. A warning letter is the FDA formally telling a company it broke the rules, and it is the single biggest reason we cannot rate Belle's oversight highly.

To be fair about where things stand: the FDA has not published a closeout letter resolving the matter. There is also no injunction, seizure, consent decree, or follow-up enforcement against Belle or any of its named pharmacy partners. Belle has since added general disclaimers to its site stating it is not the compounding pharmacy or manufacturer. But it has not yet attributed specific pharmacies to specific products the way the letter's underlying concern implies, so the fix looks partial rather than finished. That open letter is the one thing holding Belle's oversight score down. The pricing and the dietitian support are not the problem.

Who Belle is right for — and who should skip it

Belle makes sense if you want a predictable, mid-to-low monthly cost on compounded semaglutide, you value the free weekly dietitian sessions, and you appreciate that the company at least tells you which pharmacies it uses. The nine-year operating history (Belle has run since 2017), nationwide availability across all 50 states, LegitScript certification, and no-membership-fee model are all genuine points in its favor.

Skip Belle if an active FDA warning letter is a dealbreaker for you — a completely reasonable position for a medication you inject. Skip it too if you want brand-name medication, an oral option, or month-to-month tirzepatide without committing to a three-month bundle. If you're risk-averse about compounded drugs in general, this is not the provider to start with.

Bottom line

Belle Health does several things better than most compounded-GLP-1 sellers: flat pricing that doesn't punish you for dose increases, the most open pharmacy disclosure in this market, and real included dietitian coaching. But the February 2026 FDA misbranding letter is unresolved, and that holds it back. If the price and support fit your needs, go in with eyes open about the warning letter, confirm the current rates yourself, and read our scoring methodology to see exactly how the FDA action factors into Belle's rating.

For a side-by-side, Brightmeds ($100/month) and Live Vital ($130/month) are the most comparable options to weigh against Belle Health.